BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7980241)

  • 1. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
    Mulligan SP; Dean MG
    Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Montalban C; Liaño F; Aguilera A
    Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
    Ramachandran A; Majumdar G
    Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C; Coiffier B
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    Frame JN; Dahut WL; Crowley S
    N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
    Calvo-Villas JM; Urcuyo BM; Umpierrez AM; Sicilia F
    Onkologie; 2008 Apr; 31(4):197-9. PubMed ID: 18418022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
    Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
    J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Bacchu S; Fegan C; Neal J
    Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Kosseifi SG; Vyas B; Vyas H; Krishnaswamy G; Smith S
    Tenn Med; 2009 Oct; 102(10):33-6. PubMed ID: 19899317
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ; Knight L; Charan N
    West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
    Wierda WG; Byrd JC; O'Brien S; Coutre S; Barr PM; Furman RR; Kipps TJ; Burger JA; Stevens DA; Sharman J; Ghia P; Flinn IW; Zhou C; Ninomoto J; James DF; Tam CS
    Br J Haematol; 2019 Jul; 186(1):184-188. PubMed ID: 30740654
    [No Abstract]   [Full Text] [Related]  

  • 14. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 15. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
    Leporrier M; Reman O; Troussard X
    Lancet; 1993 Aug; 342(8870):555. PubMed ID: 8102691
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia.
    Ghosh K; Sivakumaran M; Murphy P; Chapman CS
    Natl Med J India; 1995; 8(6):294-5. PubMed ID: 8520454
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia.
    Braester A; Elmalah Y; Quitt M
    Leuk Lymphoma; 2003 Oct; 44(10):1835-6. PubMed ID: 14692545
    [No Abstract]   [Full Text] [Related]  

  • 18. Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia.
    Stern SC; Shah S; Costello C
    Br J Haematol; 1999 Sep; 106(3):836-7. PubMed ID: 10469479
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.